Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.70
14.02.24
€1.00
14.02.25
12.69%
15.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.35
13.02.24
€1.00
13.02.25
26.07%
14.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.11
12.02.24
€1.00
12.02.25
21.40%
13.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Tc Biopharm (holdings) Plc

Start price
Target price
Perf. (%)
€1.56
09.02.24
-
09.02.25
-39.10%
18.02.24

Could be worthwhile Investment >10% per year
buy
Man Group Ltd.

Start price
Target price
Perf. (%)
€2.72
09.02.24
-
09.02.25
2.21%
17.02.24

buy
Wimi Hologram Cloud Inc.

Start price
Target price
Perf. (%)
€1.02
08.02.24
-
08.02.25
27.45%
17.02.24

Could be worthwhile Investment >10% per year
buy
Wimi Hologram Cloud Inc.

Start price
Target price
Perf. (%)
€1.09
08.02.24
-
08.02.25
19.27%
17.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
Biorestorative Therapies Inc.

Start price
Target price
Perf. (%)
€1.36
06.02.24
-
06.02.25
2.21%
17.02.24

Capable Management
Could be worthwhile Investment >10% per year
Good culture
Few uniques
buy
Uipath Inc.

Start price
Target price
Perf. (%)
€20.90
05.02.24
€30.00
05.02.25
8.61%
17.02.24

EBIT growth >5% per year expected
Top 10 in its market
Good rating
Standard Investments for future growth
buy
Affirm Hldgs Inc

Start price
Target price
Perf. (%)
€38.10
05.02.24
€50.00
05.02.25
-6.82%
17.02.24

EBIT growth >5% per year expected
Standard Investments for future growth
Some uniques
Could be very worthwhile Investment >20% year
buy
Li-ft Power Ltd.

Start price
Target price
Perf. (%)
€3.23
05.02.24
€10.00
05.02.25
-3.41%
17.02.24

Good rating
High Investments for future growth
Revenue growth > 30% per year expected
Sustainability is little important
buy
Top Ships Inc.

Start price
Target price
Perf. (%)
€12.40
05.02.24
€26.00
05.02.25
1.61%
27.02.24

Could be very worthwhile Investment >20% year
Cantourage Group SE

Start price
Target price
Perf. (%)
€10.50
05.02.24
-
05.02.25
-16.29%
17.02.24

Risky Investment
Cannovum Cannabis AG

Start price
Target price
Perf. (%)
€3.44
05.02.24
-
05.02.25
-22.67%
17.02.24

buy
Addex Therapeutics Sa

Start price
Target price
Perf. (%)
€9.00
04.02.24
€12.00
31.05.25
148.89%
15.04.24

Could be very worthwhile Investment >20% year
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.92
03.02.24
€1.00
03.02.25
20.87%
12.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€9.89
02.02.24
-
02.02.25
-5.26%
03.02.24

Risky Investment
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.83
31.01.24
€0.000
31.01.25
11.38%
03.02.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Lava Therapeutics B.v.

Start price
Target price
Perf. (%)
€1.94
25.01.24
€2.00
25.01.25
-20.10%
03.02.24

Could be worthwhile Investment >10% per year
Good culture
Innovative
No uniques
buy
Lava Therapeutics B.v.

Start price
Target price
Perf. (%)
€1.97
25.01.24
€2.80
25.01.25
14.72%
25.01.24

Could be very worthwhile Investment >20% year
buy
Kodiak Sciences Inc.

Start price
Target price
Perf. (%)
€3.57
25.01.24
€4.80
31.08.25
24.28%
25.01.24

Could be very worthwhile Investment >20% year
buy
Redhill Biopharma Ltd.

Start price
Target price
Perf. (%)
€1.00
24.01.24
-
24.01.25
-49.20%
03.02.24

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
No Innovation
buy
Uipath Inc.

Start price
Target price
Perf. (%)
€21.70
22.01.24
€25.00
22.01.25
2.77%
03.02.24

EBIT growth >5% per year expected
Top 10 in its market
Good rating
Standard Investments for future growth
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€2.98
21.01.24
-
21.01.25
19.46%
03.02.24

Could be worthwhile Investment >10% per year
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€10.58
20.01.24
€5.00
30.04.25
-18.34%
25.01.24

Could be very worthwhile Investment >20% year